Profile | GDS4284 / 226139_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 252.076 | 54 |
GSM687648 | Patient 402 control | 215.986 | 50 |
GSM687653 | Patient 403 control | 130.324 | 41 |
GSM687658 | Patient 404 control | 349.462 | 58 |
GSM687663 | Patient 411 control | 10.5278 | 5 |
GSM687668 | Patient 422 control | 247.585 | 53 |
GSM687673 | Patient 424 control | 295.101 | 54 |
GSM687678 | Patient 425 control | 329.258 | 56 |
GSM687683 | Patient 427 control | 303.73 | 54 |
GSM687688 | Patient 428 control | 175.69 | 46 |
GSM687695 | Patient 441 control | 183.28 | 37 |
GSM687699 | Patient 443 control | 306.869 | 54 |
GSM687704 | Patient 444 control | 189.719 | 47 |
GSM687707 | Patient 448 control | 164.196 | 40 |
GSM687712 | Patient 449 control | 238.667 | 51 |
GSM687719 | Patient 450 control | 307.634 | 53 |
GSM687724 | Patient 451 control | 20.0521 | 10 |
GSM687728 | Patient 452 control | 240.195 | 51 |
GSM687646 | Patient 401 treated 24h | 296.535 | 55 |
GSM687649 | Patient 402 treated 24h | 197.64 | 49 |
GSM687665 | Patient 411 treated 24h | 243.356 | 50 |
GSM687651 | Patient 402 treated 4 weeks | 189.159 | 46 |
GSM687667 | Patient 411 treated 4 weeks | 317.411 | 56 |
GSM687670 | Patient 422 treated 24h | 266.82 | 52 |
GSM687671 | Patient 422 treated 4 weeks | 160.579 | 45 |
GSM687654 | Patient 403 treated 24h | 272.908 | 55 |
GSM687675 | Patient 424 treated 24h | 227.876 | 49 |
GSM687685 | Patient 427 treated 24h | 213.935 | 49 |
GSM687656 | Patient 403 treated 4 weeks | 152.649 | 46 |
GSM687677 | Patient 424 treated 4 weeks | 236.139 | 51 |
GSM687687 | Patient 427 treated 4 weeks | 214.89 | 51 |
GSM687692 | Patient 428 treated 4h | 264.466 | 53 |
GSM687716 | Patient 449 treated 4h | 176.89 | 47 |
GSM687722 | Patient 450 treated 4h | 229.999 | 48 |
GSM687680 | Patient 425 treated 24h | 272.336 | 54 |
GSM687690 | Patient 428 treated 24h | 267.223 | 55 |
GSM687700 | Patient 443 treated 24h | 649.614 | 66 |
GSM687705 | Patient 444 treated 24h | 275.6 | 55 |
GSM687714 | Patient 449 treated 24h | 62.0541 | 27 |
GSM687721 | Patient 450 treated 24h | 339.953 | 55 |
GSM687682 | Patient 425 treated 4 weeks | 225.444 | 52 |
GSM687694 | Patient 428 treated 4 weeks | 197.165 | 50 |
GSM687702 | Patient 443 treated 4 weeks | 305.807 | 54 |
GSM687718 | Patient 449 treated 4 weeks | 293.988 | 56 |
GSM687723 | Patient 450 treated 4 weeks | 196.269 | 47 |
GSM687661 | Patient 404 treated 4h | 270.299 | 53 |
GSM687710 | Patient 448 treated 4h | 267.421 | 54 |
GSM687726 | Patient 451 treated 4h | 209.565 | 46 |
GSM687730 | Patient 452 treated 4h | 518.109 | 57 |
GSM687660 | Patient 404 treated 24h | 275.343 | 51 |
GSM687697 | Patient 441 treated 24h | 490.524 | 62 |
GSM687709 | Patient 448 treated 24h | 51.2622 | 22 |
GSM687725 | Patient 451 treated 24h | 159.167 | 39 |
GSM687729 | Patient 452 treated 24h | 234.781 | 46 |
GSM687727 | Patient 451 treated 4 weeks | 114.325 | 33 |
GSM687731 | Patient 452 treated 4 weeks | 176.048 | 43 |